Translationally relevant mouse model of early life cancer and chemotherapy exposure results in brain and small intestine cytokine responses: A potential link to cognitive deficits

• Published in: Brain, behavior, and immunity behavior, and immunity, 2022-01, Vol.99, p.192-202
• Main Authors: Konsman, Jan Pieter, Laaker, Collin J., Lloyd, Kelsey R., Hiltz, Adam, Smith, Brittany L., Smail, Marissa A., Reyes, Teresa M.
• Format: Article
• Language: English
• Subjects: Animals; Brain - pathology; Chemotherapy; Child; Cognition; Cognitive Sciences; Cytokines; Executive function; Female; Humans; Intestine, Small; Life Sciences; Male; Mice; Neurobiology; Neurons and Cognition; Pharmaceutical sciences; Pharmacology; Precursor Cell Lymphoblastic Leukemia-Lymphoma - complications; Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy; Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology; Prefrontal cortex; Small intestine inflammation
• ISSN: 0889-1591; 1090-2139
• DOI: 10.1016/j.bbi.2021.10.003

•Early life cancer-chemotherapy results in sex-specific cognitive deficits in mice.•Acute increase in chemokine CCL2 in prefrontal cortex in males only.•White matter markers decreased in males and females.•Elevated proinflammatory cytokines in small intestine acutely and chronically.•Small intestine inflammatory gene expression is related to behavior and brain responses. Survivors of acute lymphoblastic leukemia (ALL), the most common childhood cancer, are at increased risk for long-term cognitive problems, including executive function deficits. The chemotherapeutic agent methotrexate (MTX) is used to treat most ALL patients and is closely associated with cognitive deficits. To address how early life cancer chemotherapy leads to cognitive deficits, we developed a translationally relevant mouse model of leukemia survival that exposed mice to leukemic cells and chemotherapeutic drugs (vincristine and MTX, with leucovorin rescue) in early life. Male and female mice were tested several weeks later using novel object recognition (recognition memory) and 5-choice serial reaction time task (executive function). Gene expression of proinflammatory, white matter and synapse-associated molecules was assessed in the prefrontal cortex and small intestine both acutely after chemotherapy and chronically after cognitive testing. Early life cancer-chemotherapy exposure resulted in recognition memory and executive function deficits in adult male mice. Prefrontal cortex expression of the chemokine Ccl2 was increased acutely, while small intestine expression of the proinflammatory cytokine tumor necrosis factor-alpha was elevated both acutely (both sexes) and chronically (males only). Inflammation in the small intestine was correlated with prefrontal cortical proinflammatory and synaptic gene expression changes, as well as to executive function deficits. Collectively, these data indicate that the current protocol results in a robust mouse model in which to study cognitive deficits in leukemia survivors, and suggest that small intestine inflammation may represent a novel contributor to adverse CNS consequences of early life chemotherapy.